Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells
Abstract
Oncolytic virus (OV) therapy, which is being tested in clinical trials for glioblastoma, targets cancer cells, while triggering immune cells. Yet OV sensitivity varies from patient to patient. As OV therapy is regarded as an anti-tumor vaccine, by making OV-infected cancer cells secrete immunogenic proteins, linking these proteins to transcriptome would provide a measuring tool to predict their sensitivity. A set of six patient-derived...
Paper Details
Title
Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells
Published Date
Mar 14, 2021
Journal
Volume
13
Issue
6
Pages
1287 - 1287
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History